Jing-Jing Rong

Jing-Jing Rong

Auto-generated profile, based on publicly available information

Jing-Jing Rong

Cardiology Department, Hunan Provincial People’s Hospital, Changsha, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
JRJing-Jing Rong
Jing-Jing Rong
MLMing Liang
Ming Liang
FXFengqi Xuan
Fengqi Xuan
JSJing-Yang Sun
Jing-Yang Sun
LZLi-Jun Zhao
Li-Jun Zhao
WYWeiting Yu
Weiting Yu

1 November 2017 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
JRJing-Jing Rong
Jing-Jing Rong
MLMing Liang
Ming Liang
FXFengqi Xuan
Fengqi Xuan
JSJing-Yang Sun
Jing-Yang Sun
LZLi-Jun Zhao
Li-Jun Zhao
WYWeiting Yu
Weiting Yu

14 October 2024 in Nutrition & Metabolism
Verified
Journal Article
Open access
PDF file
PZPeng-Fei Zheng
Peng-Fei Zheng
ZZZhao-Fen Zheng
Zhao-Fen Zheng
ZLZheng-Yu Liu
Zheng-Yu Liu
JHJin He
Jin He
JRJing-Jing Rong
Jing-Jing Rong
HPHong Wei Pan
Hong Wei Pan
Despite the exploration of the connections between serum low-density lipoprotein cholesterol (LDL-C) levels and aneurisms in epidemiological studies, causality remains unclear. Therefore, this study aimed to assess the causal impact of LDL-C-lowering targets (HMGCR, PCSK9, NPC1L1, CETP, APOB, and LDLR) on various forms of aneurisms using Mendelian Randomization (MR) analysis. Two genetic instruments acted as proxies for exposure to LDL-C-lowering drugs: expression quantitative trait loci of drug target genes and genetic variants linked to LDL-C near drug target genes. Summary-data-based MR (SMR), inverse-variance-weighted MR (IVW-MR), and multivariable MR (MVMR) methods were employed to compute the effect estimates. The SMR analysis revealed substantial associations between increased HMGCR expression and a heightened risk of aortic aneurism (odds ratio [OR] = 1.603, 95% confidence interval [CI] = 1.209–2.124), thoracic aortic aneurism (OR = 1.666, 95% CI = 1.122–2.475), and abdominal aortic aneurism (OR = 1.910, 95% CI = 1.278–2.856). Likewise, IVW-MR analysis demonstrated positive correlations between HMGCR-mediated LDL-C and aortic aneurism (OR = 2.228, 95% CI = 1.702–2.918), thoracic aortic aneurism (OR = 1.751, 95% CI = 1.191–2.575), abdominal aortic aneurism (OR = 4.784, 95% CI = 3.257–7.028), and cerebral aneurism (OR = 1.993, 95% CI = 1.277–3.110). Furthermore, in the MVMR analysis, accounting for body mass index, smoking, and hypertension, a significant positive relationship was established between HMGCR-mediated LDL-C levels and the development of aortic aneurisms, encompassing both thoracic and abdominal subtypes. Similarly, consistent positive associations were observed for PCSK9 and CETP genes, as well as PCSK9-mediated and CETP-mediated LDL-C levels, with the occurrence of aortic aneurism and abdominal aortic aneurism. Nonetheless, the evidence for potential associations between APOB, NPC1L1 and LDLR with specific subtypes of aortic aneurisms lacked consistent support from both SMR and IVW-MR analyses. Our MR analysis offered compelling evidence of a plausible causal link between HMGCR and an increased risk of aortic aneurism, encompassing both thoracic and abdominal types. These groundbreaking findings further bolster the case for the deployment of HMGCR inhibitors in the treatment of aortic aneurisms, including both thoracic and abdominal variants.

4 September 2015 in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Verified
Journal Article
Open access
PDF file
MLMing Liang
Ming Liang
JRJingjing Rong
Jingjing Rong
JSJingyang Sun
Jingyang Sun
TYTianming Yao
Tianming Yao
FXFengqi Xuan
Fengqi Xuan
YHYa-Ling Han
Ya-Ling Han
Severely destructive disasters can often lead to heavy casualties. Large arterial injury in disasters, particularly, often results in high mortality and morbidity. Although minimally invasive intervention has achieved positive effects in diagnosing and treating vascular injuries, it is still unavailable at the disaster area of any country due to lack of on-spot catheterization labs. This study aimed to test the feasibility of adopting interventional techniques to treat haemorrhage of large arterial injuries in remote and austere wild environments after severely destructive disasters, by using a new mobile intervention suite we developed—the mobile minimally invasive interventional shelter (MIS). Large animal models of aortic and femoral arterial injuries were established using a newly developed medium vehicle-mounted digital subtraction angiography (DSA) machine in MIS. The endovascular stent-graft exclusion and balloon occlusion combined with surgical hemostasis were performed respectively following the protocols for rapid interventional therapy. The treatment capacity of the shelter was evaluated based on its stability, surgery duration and the clinical results. The stability of the medical devices in MIS directly relates to the efficiency and success rate of interventional treatment. The newly developed vehicle-mounted DSA machine showed good imaging performance and the operation of all equipments and devices in MIS were stable in interventional procedures. All the interventional treatments for large arterial injuries were performed smoothly. The average time for treating abdominal aortic injury and femoral arterial injury was 23 ± 11 and 55 ± 17 min, respectively. And the operation success rate reached 100 %. It is feasible to perform interventional operations to control haemorrhage of large arterial injuries in MIS outside hospital. The MIS has a great potential to save patients from dying of hemorrhagic shock due to lack of effective treatment devices and approaches in remote and austere wild environments, such as in disaster areas.

9 August 2014 in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Verified
Journal Article
Open access
PDF file
TYTianming Yao
Tianming Yao
JRJingjing Rong
Jingjing Rong
MLMing Liang
Ming Liang
JSJingyang Sun
Jingyang Sun
FXFengqi Xuan
Fengqi Xuan
YHYa-Ling Han
Ya-Ling Han
There has been an increase in natural disasters in recent years, which leads to a great number of injuries and deaths. It still remains an unsolved problem to treat patients with vascular injury of solid organs effectively following natural disasters, but on-spot emergency interventional transcatheter arterial embolization (TAE) has been highly recommended to cure serious vascular injury of solid organs nowadays. Spleen is the most vulnerable abdominal organ, severe arterial hemorrhage of which can cause death if untreated timely. In this research, we aimed to study the possibility of performing emergency surgical intervention in mobile minimally invasive interventional shelter for splenic injury in the case of natural disasters.

28 August 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PZPeng Fei Zheng
Peng Fei Zheng
CHCheng-Cheng Huang
Cheng-Cheng Huang
CWChang-Lu Wang
Chang-Lu Wang
TZTing Zhou
Ting Zhou
HPHong-Wei Pan
Hong-Wei Pan
XSXiang-Jiang Shi
Xiang-Jiang Shi
The role of RNA N6-methyladenosine (m6A) modifications in modulating the immune microenvironment during ischemic stroke (IS) pathogenesis remains poorly characterized. This investigation systematically explores m6A-mediated immune regulation in IS and identifies critical immune-related biomarkers. Transcriptomic profiles from 108 IS samples were analyzed to discern m6A regulatory patterns. Single-sample gene set enrichment analysis (ssGSEA) and gene set variation analysis (GSVA) quantified immune cell infiltration and pathway activity across IS subtypes and controls. Weighted gene co-expression network analysis (WGCNA) identified m6A-associated gene modules. Two complementary machine learning approaches were applied to identify the key immune-related genes implicated in IS pathogenesis. The robustness of these findings was subsequently confirmed through a comprehensive meta-analysis integrating six independent datasets. Eight dysregulated m6A regulators distinguished IS from controls. Unsupervised clustering delineated two distinct m6A modification patterns (Clusters A/B) with divergent immune landscapes: Cluster B exhibited heightened infiltration of natural killer cells, eosinophils, and activated CD4 T cells, coupled with IL6/JAK/STAT3 pathway activation, whereas Cluster A demonstrated enrichment of immature dendritic cells and monocytes, alongside oxidative phosphorylation signaling. WGCNA identified a conserved immune-related module (black module, r = 0.68 with Cluster B) containing 322 co-expressed genes. Cross-validation by machine learning nominated five candidate biomarkers (ABCA1, CPD, PRRG4, WDR46, C19orf24) showing consistent expression trends in internal validation cohorts (Control vs. IS and Cluster A vs. B). External validation via meta-analysis confirmed WDR46 as a protective factor against IS susceptibility (odds ratio [OR] = 0.74, 95% confidence interval [CI]: 0.57–0.97), while CPD (OR = 1.46, 95% CI: 1.01–2.10) and ABCA1 (OR = 1.57, 95% CI: 1.12–2.22) were significantly associated with increased IS susceptibility, establishing their roles as risk genes. Subsequent RT-qPCR analysis in clinical samples further validated the results of the aforementioned external validation. Moreover, ROC analysis revealed an AUC of 0.88 (95% CI: 0.82–0.94) for ABCA1, 0.82 (95% CI: 0.74–0.89) for WDR46, and 0.90 (95% CI: 0.84–0.96) for CPD. This study establishes m6A epitranscriptomic remodeling as a pivotal orchestrator of immune microenvironment heterogeneity in IS. The identification of ABCA1, CPD, and WDR46 as promising biomarkers not only enhances the potential for precise diagnosis but also provides actionable targets for immunomodulatory therapy in IS.